Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Neurotoxicity Syndromes 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1

Interventions

Blood Specimen Collection 6Surveys and Questionnaires 5Observation 3Colonoscopy 3Biopsy 3Remote Patient Monitoring 2Nivolumab 2Interviews as Topic 2Gastroscopy 2trastuzumab deruxtecan 1s-formylglutathione hydrolase 1lutetium Lu 177 dotatate 1copper dotatate CU-64 1Videotape Recording 1Validation Studies as Topic 1Ultrasonography 1Tomography, X-Ray Computed 1Standard of Care 1Specimen Handling 1Single-Balloon Enteroscopy 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Quality of Life 1Proctectomy 1Mass Screening 1Magnetic Resonance Spectroscopy 1Lutetium-177 1Lutetium 1Induction Chemotherapy 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Gastrointestinal Neoplasms × Folfox protocol × Clear all
NCT05494320 2022-08-09

the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin

Ain Shams University

Unknown
120 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡